|
|
FDA Uncertainty Pushes Analyst To Lower Hims & Hers Forecast
|
|
|
|
Hims & Hers Under Fire, Stock Tanks on Federal Crackdown, Patent War
|
|
|
|
China Warning Hampers Budding Stock Market Rally But Helps Gold; Pay Attention To Historic Takaichi Win
|
|
|
|
Super Bowl Commercials 2026: Complete List Of Ads, The Companies Behind Them And Who Won Over Fans
|
|
|
|
Gold Gains Over 2%; Sally Beauty Earnings Top Views
|
|
|
|
12 Health Care Stocks Moving In Monday's Intraday Session
|
|
|
|
TD Cowen Maintains Hold on Hims & Hers Health, Lowers Price Target to $20
|
|
|
|
Citigroup Maintains Sell on Hims & Hers Health, Lowers Price Target to $16.5
|
|
|
|
Novo Nordisk Takes Legal Action Against Hims & Hers Over Wegovy Knock Offs
|
|
|
|
Hims & Hers Health shares are trading lower after the company withdrew its weight-loss pill and after Novo Nordisk filed a lawsuit against the company for patent infringement. HHS General Counsel Mike Stuart posted on social media that it referred the company to the DOJ for investigation of potential violations.
|
|